RESUMEN
Aim To study features of diagnosis and treatment of acute myocardial infarction (AMI) in Russian hospitals, results of the treatment, and early and late outcomes (6 and 12 months after AMI diagnosis); to evaluate the consistence of the treatment with clinical guidelines; and to evaluate patients' compliance with the treatment.Material and methods The program was designed for 3 years, including 24 months for recruitment of patients to the study. The study will include 10,â000 patients hospitalized with a confirmed diagnosis (I21 according to ICD-10) of ST segment elevation acute myocardial infarction (MI) (STEMI) or non-ST segment elevation MI (NSTEMI) based on criteria of the European Society of Cardiology Guidelines on Forth Universal Definition of Myocardial Infarction (2018). The follow-up period was divided into three stages: observation during the stay in the hospital and at 6 and 12 months following inclusion into the registry. The primary endpoint included cardiac death, nonfatal MI during the hospitalization and after one-year follow-up. Secondary endpoints were 6-months and one-year incidence of repeated MI, heart failure, ischemic stroke, clinically significant hemorrhage, unscheduled revascularization after discharge from the hospital, and the proportion of patients who continue on statins, antiplatelet drugs, and drugs of other groups for 6 months and 1 year.Results The inclusion of patients into the registry started in 2020 and will continue for 24 months. By the time of the article publication (June, 2021), more than 2,000 patients will be included.Conclusion REGION-MI (Russian rEGIstry Of acute myocardial iNfarction) is a multicenter, retrospective and prospective observational cohort study that excludes any interference with the clinical practice. Results of the registry will help to analyze a real picture of medical care provided to patients with myocardial infarction and to schedule ways to improve the situation.
Asunto(s)
Infarto del Miocardio , Humanos , Infarto del Miocardio/diagnóstico , Infarto del Miocardio/epidemiología , Infarto del Miocardio/terapia , Estudios Prospectivos , Sistema de Registros , Estudios Retrospectivos , Factores de Riesgo , Federación de Rusia/epidemiología , Factores de Tiempo , Resultado del TratamientoRESUMEN
The results of biochemical studies conducted in 42 patients with Huntington's chorea are presented. The authors marked the decrease of tolerance to glucose, the increase of cholesterol concentration in the blood serum in some patients. Uric acid concentration in the blood serum and its excretion with urine were decreased in all examined patients. Ceruloplasmic activity in the patients' blood did not differ from the normal level. Cuprum concentration in the blood serum and the patients' urine was within the normal fluctuations.
Asunto(s)
Enfermedad de Huntington/metabolismo , Adulto , Bilirrubina/sangre , Glucemia/análisis , Glucemia/metabolismo , Ceruloplasmina/sangre , Colesterol/sangre , Cobre/sangre , Femenino , Prueba de Tolerancia a la Glucosa , Humanos , Metabolismo de los Lípidos , Masculino , Persona de Mediana Edad , Purinas/metabolismo , Ácido Úrico/sangreRESUMEN
The author studied 40 patients with hereditary extrapyramidal diseases, including 8 cases with Hallerworden-Spatz disease, 13--with Hutchingtons chorea and 23 with torsion dystonia. For control purposes 20 normals were studied as well. The studies were aimed at determining the iron, manganese and zinc content in the blood plasma in the diurnal urine by means of an atom-absorbtional spectrophotometry on the apparatus "Perkin--Elmer-503" with the use of black lead flasks. These parameters were correlated with the clinical syndrome, severity of the condition and its duration. In order to detect the possible intercorrelations between the trace elements the method of a correlational level with determination of Spearman's coefficient was used.
